Sai Life Sciences Completes Phase-II of Production Block 11 at Bidar site
Sai Life Sciences’ Unit IV in Bidar is the company’s flagship manufacturing site, specialising in the production of APIs and advanced intermediates for markets such as the US, EU and Japan.
Contract Research, Development And Manufacturing O | 29/08/2025 | By Dineshwori | 292
WuXi Biologics, a leading global contract research, development and manufacturing organisation (CRDMO), has announced that its Dundalk, Ireland facility has been approved by the European Medicines Agency (EMA) as a commercial manufacturing site for a client’s innovative biologic.
Contract Research, Development And Manufacturing O | 18/08/2025 | By Dineshwori | 171
WuXi Biologics Unveils WuXia293Stable Platform to Advance Manufacturing of Complex Biologics
Featuring high titers, robust stability and superior quality, the platform enhances both the developability and manufacturability of complex biologics, providing an efficient chemistry, manufacturing and controls (CMC) solution for sophisticated structures and functions.
Contract Research, Development And Manufacturing O | 12/08/2025 | By Darshana | 210
Aragen Appoints Aniel Khubchandani as CEO of Development and Manufacturing Solutions Unit
Aragen, a global Contract Research, Development and Manufacturing Organisation (CRDMO), has named Aniel Khubchandani as Chief Executive Officer of its Development and Manufacturing Solutions division. He will also join Aragen’s Management Council and will be based in Hyderabad.
<br />
Contract Research, Development And Manufacturing O | 07/08/2025 | By Darshana | 191
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy